Expression of vascular endothelial growth factor receptors in human prostate cancer

By Ferrer F.A.   Miller L.J.   Lindquist R.   Kowalczyk P.   Laudone V.P.   Albertsen P.C.   Kreutzer D.L.  

Urology, Vol. 54, Iss. 3, 1999-09 ,pp. : 567-572

Elsevier

Access to resources Recommend Favorite

Selective growth of epithelial basal cells of the human prostate in a three dimensional organ culture

By Selli C.   Papini S.   Campani D.   DeMatteis A.   Revoltella R.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 19-19

Elsevier

Access to resources Recommend Favorite

The role of the insulin-like growth factor receptor, the insulin receptor substrate and PTEN in human prostate cancer progression

By Hellawell G.   Turner G.   Davies D.   Brewster S.   Macaulay V.  

European Urology Supplements, Vol. 1, Iss. 1, 2002-01 ,pp. : 33-33

Elsevier

Access to resources Recommend Favorite

Chemosensitisation of human prostate cancer using antisense agents targeting the type 1 insulin-like growth factor receptor

By Hellawell G.   Ferguson D.   Brewster S.   Macaulay V.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 36-36

Elsevier

Access to resources Recommend Favorite

Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancer

By Cvetkovic D.   Movsas B.   Dicker A.P.   Hanlon A.L.   Greenberg R.E.   Chapman J.D.   Hanks G.E.   Tricoli J.V.  

Urology, Vol. 57, Iss. 4, 2001-04 ,pp. : 821-825

Elsevier

Access to resources Recommend Favorite